CJC-1295 + Ipamorelin Blend
This blend pairs CJC-1295, a long-acting GHRH analog, with ipamorelin, a selective ghrelin-receptor agonist, combining two distinct signaling pathways that converge on the same pituitary growth hormone-releasing cells.
Endocrine research on combining GHRH analogs with ghrelin-receptor agonists has repeatedly found that co-administration produces synergistic, greater than additive growth hormone release compared with either compound given alone.
This synergy rationale is why the combination is used in research aiming to model more robust activation of the GH/IGF-1 axis.
Free shipping on orders over $150 (US & Canada).
Monday to Friday 8:00am - 06:00pm
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.








